Is Inventurus Knowledge Solutions a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Inventurus Knowledge Solutions Ltd is a good quality company .

Is Inventurus Knowledge Solutions undervalued or overvalued?

The key valuation ratios of Inventurus Knowledge Solutions Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Inventurus Knowledge Solutions share price return in the past 10 years?

Data is not available for this company

Is Inventurus Knowledge Solutions a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Inventurus Knowledge Solutions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Inventurus Knowledge Solutions?

The latest standalone P/E ratio of Inventurus Knowledge Solutions as of 15-Jan-2025 is 98.51.

What is the P/B ratio of Inventurus Knowledge Solutions?

The latest standalone P/B ratio of Inventurus Knowledge Solutions as of 15-Jan-2025 is 9.85.

What is the 52-week high and low of Inventurus Knowledge Solutions?

The 52-week high of Inventurus Knowledge Solutions is Rs. 2190.00 and the 52-week low is Rs. 1820.35.

Inventurus Knowledge Solutions Ltd - Stock Valuation and Financial Performance

Name: Inventurus Knowledge Solutions
Brand: Inventurus Knowledge Solutions

BSE: 544309 | NSE: IKS | BPO/ITeS | Small Cap

Place order

Inventurus Knowledge Share Price

₹1,915.20 -19.15 -0.99%
as on 15-Jan'25 16:59

10 Year X-Ray of Inventurus Knowledge:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	61.6%	70.4%	29.8%	20.5%	65.3%	65.3%	51.4%	47.9%	50.7%	50.5%	-
Value Creation Index ⓘ	4.5	5.3	1.7	0.8	4.8	4.8	3.6	3.3	3.5	3.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	161	203	230	262	352	388	418	560	759	873	873
Sales YoY Gr.	-	26.6%	13.4%	13.6%	34.6%	10.1%	7.8%	34%	35.5%	15%	-
Adj EPS ⓘ	0.6	2.2	1.2	0.9	5.4	7.5	8.5	12	16.5	20	19.6
YoY Gr.	-	256.5%	-44.8%	-26.2%	498.9%	39.2%	13.1%	41.8%	37%	21.6%	-
BVPS (₹) ⓘ	-2.1	0.4	1.9	3.4	9.7	13.6	22.4	30.1	37.7	48.2	196.3
Adj Net Profit ⓘ	9.7	36.1	20.2	14.5	86.9	122	139	204	277	339	337
Cash Flow from Ops. ⓘ	16.1	51.6	41.7	45.6	99.4	141	168	237	248	119	-
Debt/CF from Ops. ⓘ	4.6	1.5	1.5	1.1	0	0	0	0	0	1.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	20.7%	19.9%	27.8%	15%
Adj EPS ⓘ	47.1%	30%	33.2%	21.6%
BVPSⓘ	NA	37.9%	29%	27.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-26.2	-271.7	108.2	32.9	78.2	61.9	45.9	45.7	47.9	46.2	16.1
Op. Profit Mgn % ⓘ	14.9	26.6	18	14	28.8	35	39.7	41.7	42	45.6	NAN
Net Profit Mgn % ⓘ	6	17.8	8.8	5.6	24.7	31.5	33.2	36.4	36.5	38.8	38.6
Debt to Equity ⓘ	-2.3	13.3	2	1	0	0	0	0	0	0.2	-
Working Cap Days ⓘ	120	127	119	99	83	101	118	116	93	90	0
Cash Conv. Cycle ⓘ	87	85	63	29	6	6	8	7	8	40	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 27.82%

Net Profit is growing at healthy rate in last 3 years 33.18%

Return on Equity has declined versus last 3 years average to 16.10%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Inventurus Knowledge Solutions Ltd.

	Standalone	Consolidated
TTM EPS (₹)	19.6	21.6
TTM Sales (₹ Cr.)	873	1,818
BVPS (₹.) ⓘ	196.3	215.5
Reserves (₹ Cr.) ⓘ	3,351	3,681
P/BV ⓘ	9.85	8.97
PE ⓘ	98.51	89.58

From the Market
52 Week Low / High (₹)	1820.35 / 2190.00
All Time Low / High (₹)	1820.35 / 2190.00
Market Cap (₹ Cr.)	33,188
Equity (₹ Cr.)	17.2
Face Value (₹)	1
Industry PE ⓘ	76.5

Management X-Ray of Inventurus Knowledge:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Inventurus Knowledge

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Inventurus Knowledge

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	161	203	230	262	352	388	418	560	759	873
Operating Expenses ⓘ	139	149	189	225	253	252	252	329	444	478
Manufacturing Costs	3	4	5	5	6	6	4	5	8	9
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	70	112	150	179	202	211	222	285	359	388
Other Costs ⓘ	66	34	34	41	45	35	26	39	77	81
Operating Profit ⓘ	22	54	41	36	100	135	166	231	316	394
Operating Profit Margin (%)	13.5%	26.6%	18.0%	13.9%	28.3%	35.0%	39.6%	41.3%	41.6%	45.2%
Other Income ⓘ	0	0	1	12	24	31	16	21	28	33
Interest ⓘ	8	8	6	6	4	7	7	6	5	16
Depreciation ⓘ	5	10	15	28	33	36	26	19	20	22
Exceptional Items ⓘ	0	0	0	0	0	0	0	-20	-31	0
Profit Before Tax ⓘ	8	36	20	14	86	123	148	208	288	390
Tax ⓘ	0	0	0	0	0	1	9	19	34	53
Profit After Tax	8	36	20	14	86	122	139	189	253	337
PAT Margin (%)	5.1%	17.8%	8.8%	5.5%	24.4%	31.5%	33.3%	33.7%	33.4%	38.6%
Adjusted EPS (₹)	0.5	2.2	1.2	0.9	5.3	7.5	8.5	11.1	15.1	19.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	16%	32%	0%	66%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	-33	6	31	54	156	221	367	510	635	815
Share Capital ⓘ	8	8	8	8	8	8	8	17	17	17
Reserves ⓘ	-41	-2	23	46	148	213	359	493	618	798
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	65	65	42	38	1	0	0	0	0	138
Long Term Debt	37	56	23	10	1	0	0	0	0	0
Short Term Debt	28	9	19	28	0	0	0	0	0	138
Trade Payables	7	5	8	24	8	19	8	16	21	16
Others Liabilities ⓘ	61	75	76	40	27	83	64	100	86	77
Total Liabilities ⓘ	100	151	158	155	193	323	440	626	741	1,046
Fixed Assets
Gross Block	33	59	84	108	112	174	173	174	171	246
Accumulated Depreciation	17	27	42	27	60	84	101	111	121	130
Net Fixed Assetsⓘ	16	32	42	81	52	90	72	63	49	116
CWIP ⓘ	14	26	36	0	0	0	0	0	0	0
Investmentsⓘ	4	4	4	5	6	5	16	16	19	473
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	57	56	40	40	17	37	26	38	66	198
Cash Equivalents ⓘ	1	12	1	1	44	103	204	336	495	205
Others Assetsⓘ	8	19	34	28	75	86	121	172	112	54
Total Assets ⓘ	100	151	158	155	193	323	440	626	741	1,046

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	16	52	42	46	99	141	168	237	248	119
PBT ⓘ	8	36	20	14	86	123	148	208	288	390
Adjustment ⓘ	16	20	21	35	40	42	18	23	29	6
Changes in Working Capital ⓘ	-8	3	3	-0	-11	1	18	44	-19	-203
Tax Paid ⓘ	0	-7	-3	-4	-16	-25	-17	-37	-50	-73
Cash Flow From Investing Activity ⓘ	-21	-38	-35	-29	-12	-80	-165	-81	-141	-149
Capex	-21	-39	-36	-29	-5	-11	104	-9	-8	-20
Net Investments	0	0	0	0	0	-72	-274	-83	-156	300
Others ⓘ	0	0	0	0	-6	4	5	11	23	-429
Cash Flow From Financing Activityⓘ	5	-2	-18	-16	-51	-36	-32	-54	-148	-186
Net Proceeds from Shares ⓘ	0	2	5	0	2	1	2	4	15	3
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-10	-8	-6	-6	-4	-6	-7	-6	-14	-15
Dividend Paid ⓘ	0	0	0	0	0	-19	-19	-44	0	-165
Others ⓘ	15	5	-17	-10	-49	-12	-9	-9	-149	-9
Net Cash Flow ⓘ	0	12	-12	1	37	25	-30	102	-40	-216

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	N/A	0	108.18	33.62	81.51	64.82	47.3	43.06	44.29	46.48
ROCE (%)	N/A	70.37	29.81	20.52	65.31	65.31	51.39	47.86	50.68	50.53
Asset Turnover Ratio	2.13	1.62	1.49	1.67	2.02	1.5	1.1	1.05	1.11	0.98
PAT to CFO Conversion(x)	2	1.44	2.1	3.29	1.15	1.16	1.21	1.25	0.98	0.35
Working Capital Days
Receivable Days	103	102	77	56	30	25	28	21	25	55
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Inventurus Knowledge Solutions Ltd Stock News

Inventurus Knowledge Solutions Ltd FAQs

What is the share price of Inventurus Knowledge?

Company share prices are keep on changing according to the market conditions. The closing price of Inventurus Knowledge on 15-Jan-2025 16:59 is ₹1,915.2.

What is the market cap of Inventurus Knowledge?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Jan-2025 16:59 the market cap of Inventurus Knowledge stood at ₹33,188.3.

What is the P/E ratio of Inventurus Knowledge?

The latest P/E ratio of Inventurus Knowledge as of 15-Jan-2025 16:59 is 98.51.

What is the P/B ratio of Inventurus Knowledge?

The latest P/B ratio of Inventurus Knowledge as of 15-Jan-2025 16:59 is 9.85.

What is the 52-week high and low of Inventurus Knowledge?

The 52-week high of Inventurus Knowledge is ₹2,190 and the 52-week low is ₹1,820.4.

What is the TTM revenue of Inventurus Knowledge?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Inventurus Knowledge is ₹872.7 ( Cr.) .

About Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions limited was incorporated on September 5, 2006, as a private limited company under the Companies Act, 1956, with the name, ‘Inventurus Knowledge Solutions Private Limited’ pursuant to a certificate of incorporation issued by the Registrar of Companies, Goa, Daman and Diu. pursuant to a special resolution dated June 10, 2019. On the conversion of the company to a public limited company, pursuant to a resolution passed by its Board on October 14, 2022 and its Shareholders on October 17, 2022, the name of the company was changed to ‘Inventurus Knowledge Solutions Limited’, consequent to which a fresh certificate of incorporation dated November 4, 2022, was issued by the Registrar of Companies (RoC).

The company is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It is a partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the ‘fee for value’ model while optimizing their revenue and reducing operating costs. With the evolution and consolidation of the healthcare industry, it provides solutions that address these increasing tasks, or 'chores', and enable healthcare delivery enterprises to focus on their core focus of healthcare, by taking over chores that are necessary to manage their business. It does this through a blend of pragmatic technology and global human capital, with the aim of enabling healthcare delivery enterprises deliver better, safer and cost-effective care.

It offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility, and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services. Inpatient care, refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.

Business area of the company

Awards and accreditations

2019: Healthcare leadership award, 2019 by ABP news for contribution in the healthcare industry.
2020: L&D innovation and tech awards, 2020 by DISPRZ for best blended learning strategy.
2021: POSH awards, 2021 by KelpHR for being part of top 25 safest workplaces in India.
2021: TISS LeapVault award, 2021 in the best remote working program.
2022: 12th Aegis Graham Bell award, 2022 for being part of top three finalist in the category of innovation in Analytics.
2022: Technology Excellence award, 2022 for best data science project in the healthcare category.

History and milestones

2006: Incorporation of the company Investment by Rekha Jhunjhunwala, one of its Promoters.
2007: Onboarded its first client.
2009: Set up a new office space situated in an SEZ in Hyderabad, India.
2013: Set up a new office space situated in an SEZ in Mumbai, India.
2014: It turned EBITDA positive.
2015: Expanded its office space situated in an SEZ in Hyderabad, India.
2016: Registered ‘IKS Health’ brand and logo with the United States Patent and Trademark Office.
2022: Conversion of the company from Private Limited to Public Limited Company Crossed revenue of $100 million.
2023 Acquisition of Aquity Holdings, Inc. by IKS Inc.